Absorption Pharmaceuticals to conduct clinical trials of Promescent with Kaiser

NEW YORK — Absorption Pharmaceuticals will be conducting clinical trials with Kaiser to measure the efficacy of the company's over-the-counter solution for PE Promescent, CNBC reported Tuesday. 

Beginning next week, Kaiser will follow 150 men who suffer from premature ejaculation and will be given either Promescent or a placebo over the course of the next year. Patients are being recruited from the San Diego and Los Angeles markets, according to the report.  

Absorption has also released a new commercial in support of Promescent. 

Comments

- 5:24 PM
ThomasP says

I have been following Promescent since they had an article come out last October on CNBC. The product was developed by Urologists and is rapidly becoming the treatment embraced by the medical community. It has an absorption technology that penetrates the top layer of skin and desensitizes the nerves in the penis. Promescent has no transference to your partner, allows the men retain sensation, is safe and easy to use. Promescent seems to offers a legitimate medical solution to those with PE or to those who would just like to prolong the experience. Wish I had developed this product, so much potential. Here is a link to the old CNBC article as well as another one that came out this morning. http://www.cnbc.com/id/101084377 http://www.cnbc.com/id/101260806

Login or Register to post a comment.